Skip to Main Content
Menu Button
About
Team
Investors
Science
Our Approach
Partners
Publications
Pipeline
Life at Mestag
Our Culture
Team Mestag
Opportunities
News & Events
Press Releases
Events & Presentations
Contact
News & Events
LEADERSHIP
Press Releases
Events & Presentations
Mestag Presents Preclinical Data at AACR on its M300 Program, a Conditionally Active LTBR Agonist Designed to Induce Tertiary Lymphoid Structures in Tumors
April 8, 2024
Read More
Mestag Therapeutics’ M300 Program, Designed to Conditionally Induce Tertiary Lymphoid Structures in Tumors, Selected for Late-Breaking Poster Presentation at AACR Annual Meeting
March 5, 2024
Read More
Mestag Therapeutics to Present at Evercore ISI 2024 Emerging Biotech Conference
February 28, 2024
Read More
Mestag Therapeutics Enlists Leading Cancer Biology and Immunology Advisors to Support Clinical Development of its Lead Oncology Program
February 20, 2024
Read More
Mestag Therapeutics announces the appointment of expert advisors Dr. Cassandra Choe-Juliak, Dr. Greg Elson and Samantha Vieira MBA
October 12, 2023
Read More
View All Press Releases
Evercore ISI 2024 Emerging Biotech Conference
February 28, 2024
Access Webcast
AACR Annual Meeting – San Diego
Poster Presentation - Abstract #LB123
April 8, 2024 | 9:00 am PT
Contact Us for Poster
Immuno 2024 – London
M300 Program Presentation
April 26, 2024 | 9:00 am BST
Conference Website
LSX World Congress – London
Corporate Presentation
April 29, 2024 | 11:30 am BST
Conference Website
BioEquity Europe – San Sebastian, Spain
May 12-14, 2024
Contact Us to Connect
